Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Oklahoma for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Oklahoma only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Oklahoma (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Ceiara Burchett (NPI 1508519000)

Field	Value
Entity Type	Individual
Organization	Ceiara Burchett
Address	7307 S Yale Ave Ste 101
City	Tulsa
State	OK
ZIP	74136
Taxonomy	Family Nurse Practitioner
NPI Enumerated	February 3, 2022

Payer Source	Total Paid
Medicare	$1.3M
Medicaid	$0

Key Findings

Medicare revenue is highly concentrated: this provider reports $1.3M in total Medicare revenue with the top three Medicare codes accounting for 99.1% of that total. J2350 alone accounts for $1.1M (84.3%), J3111 contributes $179.8K (14.0%), and 96365 adds $9.9K (0.8%), indicating that a very small set of services drives nearly all Medicare dollars.

The service mix points to an infusion/specialty-injectable practice model rather than broad primary care. The two largest codes, J2350 (injection, ocrelizumab) and J3111 (injection, romosozumab-aqqg), are drug administration codes and the presence of 96365 (initial IV infusion up to one hour) confirms on-site infusion capabilities and routine administration of biologic injectables.

This provider is effectively single-payer at present: Medicare accounts for $1.3M in lifetime revenue while there is no Medicaid billing on file. The absence of Medicaid activity suggests the provider’s billing footprint and revenue risk are concentrated entirely in Medicare reimbursement dynamics and policies.

Competitive standing for the largest drug line is above average nationally but not an extreme outlier: J2350 ranks #12 of 105 providers nationally (89th percentile) and is characterized in the source data as "typical, unremarkable volume". That placement implies the provider is a relatively high-volume biller of ocrelizumab compared with peers but not a dominant national outlier.

For the secondary revenue drivers the provider shows moderate national presence. J3111 ranks #277 of 970 providers (71th percentile; typical, unremarkable volume) and 96365 ranks #1230 of 8873 providers (86th percentile; typical, unremarkable volume), indicating respectable percentile placements for both the romosozumab administration and the initial IV infusion service while still being labeled typical in volume.

The provider’s NPI was enumerated on 2022-02-03 (~4 years ago), so this revenue profile has been built in a relatively short operating window. Generating $1.3M in Medicare revenue since that enumeration suggests rapid uptake of specialty injection/infusion services in the practice’s early years.

From a risk and contracting perspective, revenue concentration in two drug codes creates sensitivity to reimbursement or utilization changes for those specific biologics. Because $1.1M (84.3%) is tied to J2350 and $179.8K (14.0%) to J3111, any payer policy, supply, or clinical-guideline shifts affecting those medications would materially affect the provider’s Medicare income.

No codes in the provided list are described as statistical outliers or flagged for unusual billing patterns in the source notes; the majority are labeled "typical, unremarkable volume." That means payer review should focus on the normal clinical and reimbursement considerations for high-volume biologic administration rather than anomaly-driven investigations.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

9 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2350	Injection, ocrelizumab, 1 mg	25,800	$40	$1.1M
J3111	Injection, romosozumab-aqqg, 1 mg	22,470	$10	$179.8K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	260	$40	$9.9K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	90	$80	$6.8K
96372	A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician…	280	$10	$2.5K
96415	In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the…	100	$20	$1.7K
96375	Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the…	80	$10	$740
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	80	$1	$320
J1200	Injection, diphenhydramine hcl, up to 50 mg	20	$1	$20

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 9 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Oklahoma Distribution

Ceiara Burchett — 1 of 9 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Oklahoma

Full comparison — all codes billed, vs. state median

9 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2350	1	10	17,400	$40	$745K
J3111	8	20	22,470	$10	$216.7K
96413	40	60	210	$90	$26.4K
96365	14	80	60	$40	$6.9K
96415	23	40	130	$20	$3.7K
96375	22	40	80	$10	$3.1K
96372	86	1,250	50	$10	$1.2K
J2930	9	40	40	$1	$590
J1200	28	30	70	$1	$80

Related Providers

Other providers that share a Tax Identification Number (TIN) with Ceiara Burchett, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Iftikhar Hussain	OK	Allergy & Immunology (Internal Medicine) Physician	$84.6K	$0

Nearby Providers

Other providers in the same ZIP code as Ceiara Burchett, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Saint Francis Hospital, Inc.	OK	General Acute Care Hospital	$0	$43.2M
Warren Clinic Inc	OK	General Practice Physician	$0	$40.2M
Specialized Home Nursing, Inc.	OK	Home Health Agency	$0	$21.5M
Saint Francis Outreach Services LLC	OK	Clinical Medical Laboratory	$5.4M	$15.7M
Improving Lives Counseling Services, Inc.	OK	Community/Behavioral Health Agency	$0	$21.1M
Preferred Family Health Care, Inc.	OK	Community/Behavioral Health Agency	$0	$19.4M
Osu Center For Health Sciences	OK	Medical Specialty Clinic/Center	$0	$18.9M
Emergency Medicine Physicians Of Tulsa County, LLC	OK	Emergency Medicine Physician	$0	$18M
Osu Center For Health Sciences	OK	Medical Specialty Clinic/Center	$0	$14.1M
Home Therapy Resources, Inc.	OK	Pediatric Physical Therapist	$0	$9.4M

Ceiara Burchett — Billing Profile & Reimbursement Data

Sign up for Ceiara Burchett — Billing Profile & Reimbursement Data policy alerts

Ceiara Burchett — Billing Profile & Reimbursement Data

Sign up for Ceiara Burchett — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References